| VITEK REVEAL GN AST Assay and VITEK REVEAL AST System (K260160) | bioMerieux, Inc. | 2026-07-08 |
| VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance (K260282) | bioMerieux, Inc. | 2026-04-15 |
| VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) (K251579) | bioMerieux, Inc. | 2025-08-21 |
| VITEK COMPACT PRO (K234012) | bioMerieux, Inc. | 2025-03-14 |
| VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL) (K232967) | bioMerieux, Inc. | 2024-06-12 |
| VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL) (K232963) | bioMerieux, Inc. | 2024-06-07 |
| VIDAS TBI (GFAP, UCH-L1) (K240279) | bioMerieux, Inc. | 2024-05-01 |
| VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) (K234000) | bioMerieux, Inc. | 2024-03-11 |
| VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin (K232201) | bioMerieux, Inc. | 2023-10-23 |
| VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (K230864) | bioMerieux, Inc. | 2023-07-05 |
| VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) (K222378) | bioMerieux, Inc. | 2023-06-26 |
| VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (K223478) | bioMerieux, Inc. | 2023-02-16 |
| VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) (K222073) | bioMerieux, Inc. | 2023-02-09 |
| VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) (K223481) | bioMerieux, Inc. | 2023-02-03 |
| VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin (K220803) | bioMerieux, Inc. | 2023-01-27 |
| VITEK 2 AST-Gram Positive Cefoxitin Screen (K220805) | bioMerieux, Inc. | 2022-10-13 |
| VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) (K212243) | bioMerieux, Inc. | 2022-08-08 |
| VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (K213899) | bioMerieux, Inc. | 2022-07-12 |
| VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) (K213931) | bioMerieux, Inc. | 2022-06-03 |
| VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) (K214023) | bioMerieux, Inc. | 2022-04-14 |
| VITEK MS PRIME (K212461) | bioMerieux, Inc. | 2022-03-15 |
| VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (K213241) | bioMerieux, Inc. | 2022-02-25 |
| VITEK 2 AST-Gram Positive Linezolid (<=0.5 – >=8 µg/mL) (K212849) | Biomérieux, Inc. | 2022-02-04 |
| VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) (K210287) | bioMerieux, Inc. | 2021-10-28 |
| VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) (K202396) | bioMerieux, Inc. | 2021-09-14 |
| VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) (K211630) | bioMerieux, Inc. | 2021-08-30 |
| VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) (K201675) | bioMerieux, Inc. | 2021-07-09 |
| VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) (K211136) | bioMerieux, Inc. | 2021-06-14 |
| VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) (K193299) | bioMerieux, Inc. | 2020-09-28 |
| VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) (K200590) | bioMerieux, Inc. | 2020-04-28 |
| VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) (K193572) | bioMerieux, Inc. | 2020-03-13 |
| VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL) (K193567) | bioMerieux, Inc. | 2020-02-14 |
| Vitek Densichek (K192110) | bioMerieux, Inc. | 2019-10-31 |
| VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) (K191766) | bioMerieux, Inc. | 2019-08-05 |
| VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) (K190616) | bioMerieux, Inc. | 2019-06-06 |
| BACT/ALERT MP Reagent System (K190405) | bioMerieux, Inc. | 2019-05-15 |
| VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) (K183524) | bioMerieux, Inc. | 2019-03-12 |
| VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) (K183551) | bioMerieux, Inc. | 2019-03-07 |
| VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL) (K183360) | bioMerieux, Inc. | 2019-02-26 |
| VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) (K183415) | bioMerieux, Inc. | 2019-02-20 |
| BacT/ALERT FA Plus; BacT/ALERT PF Plus (K183166) | bioMerieux, Inc. | 2019-02-11 |
| VITEK MS (K181412) | bioMerieux, Inc. | 2018-12-21 |
| VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance (K181766) | bioMerieux, Inc. | 2018-12-10 |
| VITEK 2 AST-YS Micafungin (<=0.06 - =>8 µg/mL) (K181368) | bioMerieux, Inc. | 2018-06-20 |
| VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 – >=16 µg/mL (K172944) | bioMerieux, Inc. | 2017-12-19 |
| VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) (K172731) | bioMerieux, Inc. | 2017-12-08 |
| Etest Ceftazidime/Avibactam (CZA) (0.016 - 256 ug/mL) (K172150) | bioMerieux, Inc. | 2017-09-15 |
| VITEK MS (K162950) | bioMerieux, Inc. | 2017-07-22 |
| VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL) (K162737) | bioMerieux, Inc. | 2017-06-21 |
| Etest Ceftolozane/ Tazobactam (0.016-256 ug/ml) (K170670) | bioMerieux, Inc. | 2017-05-31 |
| BacT/ALERT VIRTUO Microbial Detection System, BacT/ALERT VIRTUO, VIRTUO (K161816) | bioMerieux, Inc. | 2017-03-28 |
| VITEK 2 AST-GN Gentamicin (<=1 – >=16 µg/mL) (K163563) | bioMerieux, Inc. | 2017-03-13 |
| VIDAS B.R.A.H.M.S. PCT (PCT) (K162827) | bioMerieux, Inc. | 2017-02-23 |
| VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) (K161437) | bioMerieux, Inc. | 2017-02-16 |
| VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) (K161510) | bioMerieux, Inc. | 2017-02-13 |
| VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) (K163083) | bioMerieux, Inc. | 2017-02-01 |
| chromID Strepto B agar (K163042) | bioMerieux, Inc. | 2017-01-27 |
| VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) (K163006) | bioMerieux, Inc. | 2017-01-24 |
| VITEK 2 Gram Negative Ceftriaxone (<=0.25->=64 ug/mL) (K161217) | bioMerieux, Inc. | 2017-01-12 |
| chromID MRSA (K162076) | bioMerieux, Inc. | 2016-10-25 |
| VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL) (K161227) | bioMerieux, Inc. | 2016-07-20 |
| VIDAS B.R.A.H.M.S. PCT (PCT) (K160911) | bioMerieux, Inc. | 2016-06-28 |
| VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL) (K152075) | bioMerieux, Inc. | 2016-04-15 |
| VITEK 2 AST-Yeast Micafungin (0.06-8 mcg/mL) (K151923) | bioMerieux, Inc. | 2016-03-25 |
| chromID MRSA (K151688) | bioMerieux, Inc. | 2016-03-11 |
| VITEK 2 AST-YS Caspofungin <=0.125 - >=8 ug/mL (K151817) | bioMerieux, Inc. | 2016-02-18 |
| VITEK 2 AST YS FLUCYTOSINE, VITEK 2 AST YEAST FLUCYTOSINE (K133952) | bioMerieux, Inc. | 2014-08-19 |
| VITEK 2 AST - YEAST FLUCONAZOLE (K133817) | bioMerieux, Inc. | 2014-08-05 |
| VITEK 2 AST GP CEFTAROLINE (K141149) | bioMerieux, Inc. | 2014-06-20 |
| VITEK 2 AST ST MEROPENEM (K132507) | bioMerieux, Inc. | 2013-11-15 |
| VITEK 2 AST-ST TIGECYCLINE (K131779) | bioMerieux, Inc. | 2013-10-10 |
| VITEK 2 AST ST MOXIFLOXACIN, VITEK 2 AST STREPTOCOCCUS MOXIFLOXACIN (K132573) | bioMerieux, Inc. | 2013-09-13 |
| VITEK MS (DEN130013) | bioMerieux, Inc. | 2013-08-21 |
| BACT/ALERT FN PLUS CULTURE BOTTLE (K121455) | bioMerieux, Inc. | 2013-01-25 |
| BACT/ALERT PF PLUS CULTURE BOTTLE (K121446) | bioMerieux, Inc. | 2013-01-25 |
| BACT/ALERT FA PLUS CULTURE BOTTLE (K121461) | bioMerieux, Inc. | 2013-01-22 |
| VITEK 2 GRAM NEGATIVE DOXYCYCLINE (K121546) | bioMerieux, Inc. | 2012-11-20 |
| VITEK 2 AST STREPTOCOCUS VANCOMYCIN (K121100) | bioMerieux, Inc. | 2012-11-19 |
| GRAM POSTITVE CLINDAMYCIN (K122547) | bioMerieux, Inc. | 2012-10-15 |
| ETEST CEFTAROLINE (K121002) | bioMerieux, Inc. | 2012-10-12 |
| VITEK 2 STRPTOCOCCUS CEFTRIAXONE (K122359) | bioMerieux, Inc. | 2012-08-28 |
| VITEK 2 AST-ST CEFOTAXIME (K121863) | bioMerieux, Inc. | 2012-08-16 |
| VITEK 2 AST- GRAM POSTIVE PENICILLIN FOR STREPTOCOCCUS PNEUMONIAE (K113783) | bioMerieux, Inc. | 2012-08-07 |
| VIDAS D-DIMER EXCLUSION II (DEX2) (K112818) | bioMerieux, Inc. | 2012-07-31 |
| VITEK 2 AST-GN PIPERACILLIN/TAZOBACTAM (K113200) | bioMerieux, Inc. | 2012-06-29 |
| VITEK(R) 2 STREPTOCOCCUS TETRACYCLINE (K111893) | bioMerieux, Inc. | 2012-02-28 |
| VITEK 2 STREPTOCOCCUS ERYTHROMYCIN (K111976) | bioMerieux, Inc. | 2012-02-17 |
| VITEK 2 STREPTOCOCCUS TRIMETHOPRIM/SULFAMETHOXAZOLE (K113305) | bioMerieux, Inc. | 2012-02-10 |
| VITEK 2 GRAM NEGATIVE TRIMETHOPRIM/SULFAMETHOAZOLE (K110106) | bioMerieux, Inc. | 2011-11-30 |
| VITEK 2 STREPTOCOCCUS PENICILLIN (K112000) | bioMerieux, Inc. | 2011-10-26 |
| VITEK 2 STREPTOCOCCUS INDUCIBLE CLINDAMYCIN RESISTANCE (K111909) | bioMerieux, Inc. | 2011-10-18 |
| VITEK 2 SYSTEMS (PC) 5.02 SOFTWARE (K103752) | bioMerieux, Inc. | 2011-10-14 |
| VITEK 2 STREPTOCOCCUS LEVOFLOXACIN (K112228) | bioMerieux, Inc. | 2011-10-03 |
| VITEK(R) 2 STREPTOCOCCUS CLINDAMYCIN (K112129) | bioMerieux, Inc. | 2011-09-27 |
| VITEK 2 STRPTOCOCCUS AMPICILLIN (K112075) | bioMerieux, Inc. | 2011-09-15 |
| VITEK 2 AST-ST LINEZOLID (K111599) | bioMerieux, Inc. | 2011-08-12 |
| NUCLISENS EASYQ MRSA; NUCLISENS EASYQ ANALYZER; NUCLISENS EASYQ INCUBATOR (110 VOLT); NUCLISENS DIRECTOR V.2.6 (K102740) | bioMerieux, Inc. | 2011-05-20 |
| VIDAS TOXO IGG AVIDITY (K101946) | bioMerieux, Inc. | 2011-05-18 |
| VITEK 2 GRAM POSITIVE DOXCYCLINE (K093076) | bioMerieux, Inc. | 2010-10-21 |
| VITEK 2 YEAST CASPOFUNGIN (K101566) | bioMerieux, Inc. | 2010-09-28 |